The Q2 earnings report for ResMed (NYSE:RMD) was released on Thursday, January 30, 2025 at 04:05 PM.

Here's what investors need to know about the latest announcement.

Earnings

ResMed beat estimated earnings by 5.0%, reporting an EPS of $2.43 versus an estimate of $2.31.

Revenue was up $119.00 million from the same period last year.

Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.16, leading to a 7.000000000000001% increase share price change the next day.

Here's a look at ResMed's past performance:

To track all earnings releases for ResMed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.